Eisai
4523.T
$44.44
Share price
0.84%
Change (1 day)
-27.19%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Market capitalization of Eisai (4523.T)
Market cap: A$12.53 Billion
As of April 2025 Eisai has a market cap of A$12.53 Billion. This makes Eisai the world's 1953th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eisai from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$12.53 B | 0.27% |
| 2024 | A$12.50 B | -40.6% |
| 2023 | A$21.05 B | -23.25% |
| 2022 | A$27.43 B | 22.22% |
| 2021 | A$22.44 B | -15.76% |
| 2020 | A$26.64 B | -13.58% |
| 2019 | A$30.83 B | -1.54% |
| 2018 | A$31.31 B | 50.34% |
| 2017 | A$20.82 B | -8.99% |
| 2016 | A$22.88 B | -12.79% |
| 2015 | A$26.24 B | 92.52% |
| 2014 | A$13.63 B | 9.83% |
| 2013 | A$12.41 B | 8.07% |
| 2012 | A$11.48 B | 0.76% |
| 2011 | A$11.39 B | 12.61% |
| 2010 | A$10.12 B | -13.3% |
| 2009 | A$11.67 B | -31.96% |
| 2008 | A$17.15 B | 28.35% |
| 2007 | A$13.36 B | -32.94% |
| 2006 | A$19.93 B | 21.64% |
| 2005 | A$16.38 B | 34.04% |
| 2004 | A$12.22 B | 13.87% |
| 2003 | A$10.73 B | -7.65% |
| 2002 | A$11.62 B | -19.17% |
| 2001 | A$14.38 B | -22.44% |
| 2000 | A$18.54 B |
End of Day market cap according to different sources
On Apr 22nd, 2025 the market cap of Eisai was reported to be:
A$12.56 Billion
A$12.56 Billion